Bruker Cash vs Accounts Payable Analysis

BRKR Stock

USD 58.38 0.88 1.53%

Bruker financial indicator trend analysis is way more than just evaluating Bruker prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bruker is a good investment. Please check the relationship between Bruker Cash and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

Cash vs Accounts Payable

Cash vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bruker Cash account and Accounts Payable. At this time, the significance of the direction appears to have very week relationship.

The correlation between Bruker's Cash and Accounts Payable is 0.21. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Bruker, assuming nothing else is changed. The correlation between historical values of Bruker's Cash and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Bruker are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Cash i.e., Bruker's Cash and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.21

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Cash

Cash refers to the most liquid asset of Bruker, which is listed under current asset account on Bruker balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Bruker customers. The amounts must be unrestricted with restricted cash listed in a different Bruker account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Accounts Payable

An accounting item on the balance sheet that represents Bruker obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bruker are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Bruker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Selling General Administrative is relatively stable compared to the past year. As of 11/29/2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop slightly above 82.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.2B	1.3B	1.5B	1.6B
Total Revenue	2.4B	2.5B	3.0B	3.1B

Gross Profit Total Revenue

Bruker fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.97	0.96	0.42	0.85	0.34	0.96	-0.9	0.99	0.96	0.42	0.95	0.96	0.85	0.97	0.53	0.65	0.58	0.95	0.55	0.95	0.14	0.85	0.76	0.26	0.22
Total Stockholder Equity	0.97		0.92	0.38	0.75	0.49	0.88	-0.81	0.94	0.87	0.49	0.95	0.94	0.78	0.93	0.5	0.57	0.52	0.95	0.66	0.96	0.13	0.84	0.73	0.23	0.33
Non Current Assets Total	0.96	0.92		0.55	0.91	0.14	0.92	-0.95	0.95	0.94	0.34	0.91	0.98	0.95	0.98	0.53	0.44	0.35	0.95	0.37	0.91	0.01	0.95	0.57	0.26	0.14
Non Currrent Assets Other	0.42	0.38	0.55		0.51	-0.24	0.38	-0.45	0.42	0.44	-0.39	0.46	0.54	0.6	0.46	0.22	-0.05	-0.07	0.33	-0.1	0.39	-0.06	0.73	-0.04	0.28	-0.2
Other Assets	0.85	0.75	0.91	0.51		-0.11	0.9	-0.96	0.88	0.91	0.24	0.75	0.86	0.92	0.92	0.4	0.44	0.38	0.79	0.14	0.74	-0.13	0.83	0.49	0.26	-0.12
Common Stock Shares Outstanding	0.34	0.49	0.14	-0.24	-0.11		0.16	0.04	0.27	0.13	0.42	0.44	0.27	-0.07	0.19	0.3	0.34	0.41	0.35	0.93	0.46	0.48	0.1	0.56	0.07	0.53
Non Current Liabilities Total	0.96	0.88	0.92	0.38	0.9	0.16		-0.94	0.98	0.99	0.42	0.84	0.9	0.84	0.96	0.43	0.72	0.66	0.88	0.39	0.84	0.06	0.78	0.75	0.26	0.17
Other Stockholder Equity	-0.9	-0.81	-0.95	-0.45	-0.96	0.04	-0.94		-0.92	-0.94	-0.35	-0.79	-0.89	-0.93	-0.96	-0.45	-0.5	-0.42	-0.87	-0.23	-0.79	0.08	-0.83	-0.58	-0.34	-0.08
Total Liab	0.99	0.94	0.95	0.42	0.88	0.27	0.98	-0.92		0.98	0.39	0.93	0.95	0.86	0.97	0.54	0.67	0.61	0.93	0.49	0.93	0.14	0.84	0.76	0.26	0.17
Short Long Term Debt Total	0.96	0.87	0.94	0.44	0.91	0.13	0.99	-0.94	0.98		0.35	0.87	0.92	0.87	0.95	0.49	0.69	0.61	0.89	0.36	0.86	0.07	0.82	0.72	0.25	0.09
Other Current Liab	0.42	0.49	0.34	-0.39	0.24	0.42	0.42	-0.35	0.39	0.35		0.29	0.34	0.23	0.43	-0.19	0.38	0.38	0.51	0.5	0.38	-0.36	0.17	0.53	-0.02	0.48
Total Current Liabilities	0.95	0.95	0.91	0.46	0.75	0.44	0.84	-0.79	0.93	0.87	0.29		0.95	0.82	0.88	0.68	0.5	0.44	0.93	0.61	0.99	0.28	0.87	0.68	0.24	0.15
Property Plant And Equipment Net	0.96	0.94	0.98	0.54	0.86	0.27	0.9	-0.89	0.95	0.92	0.34	0.95		0.91	0.95	0.54	0.46	0.38	0.94	0.47	0.96	0.08	0.95	0.61	0.26	0.15
Net Debt	0.85	0.78	0.95	0.6	0.92	-0.07	0.84	-0.93	0.86	0.87	0.23	0.82	0.91		0.91	0.51	0.26	0.18	0.87	0.17	0.8	-0.1	0.94	0.39	0.3	-0.05
Retained Earnings	0.97	0.93	0.98	0.46	0.92	0.19	0.96	-0.96	0.97	0.95	0.43	0.88	0.95	0.91		0.46	0.54	0.49	0.94	0.42	0.88	-0.01	0.88	0.65	0.3	0.2
Accounts Payable	0.53	0.5	0.53	0.22	0.4	0.3	0.43	-0.45	0.54	0.49	-0.19	0.68	0.54	0.51	0.46		0.21	0.12	0.57	0.4	0.63	0.74	0.5	0.36	0.23	0.11
Cash	0.65	0.57	0.44	-0.05	0.44	0.34	0.72	-0.5	0.67	0.69	0.38	0.5	0.46	0.26	0.54	0.21		0.96	0.47	0.48	0.51	0.28	0.21	0.9	0.06	0.26
Cash And Short Term Investments	0.58	0.52	0.35	-0.07	0.38	0.41	0.66	-0.42	0.61	0.61	0.38	0.44	0.38	0.18	0.49	0.12	0.96		0.39	0.52	0.43	0.24	0.14	0.87	0.09	0.21
Net Receivables	0.95	0.95	0.95	0.33	0.79	0.35	0.88	-0.87	0.93	0.89	0.51	0.93	0.94	0.87	0.94	0.57	0.47	0.39		0.55	0.95	0.08	0.86	0.66	0.29	0.26
Common Stock Total Equity	0.55	0.66	0.37	-0.1	0.14	0.93	0.39	-0.23	0.49	0.36	0.5	0.61	0.47	0.17	0.42	0.4	0.48	0.52	0.55		0.63	0.42	0.3	0.76	0.16	0.59
Inventory	0.95	0.96	0.91	0.39	0.74	0.46	0.84	-0.79	0.93	0.86	0.38	0.99	0.96	0.8	0.88	0.63	0.51	0.43	0.95	0.63		0.23	0.86	0.69	0.24	0.21
Other Current Assets	0.14	0.13	0.01	-0.06	-0.13	0.48	0.06	0.08	0.14	0.07	-0.36	0.28	0.08	-0.1	-0.01	0.74	0.28	0.24	0.08	0.42	0.23		-0.03	0.29	0.11	0.28
Property Plant And Equipment Gross	0.85	0.84	0.95	0.73	0.83	0.1	0.78	-0.83	0.84	0.82	0.17	0.87	0.95	0.94	0.88	0.5	0.21	0.14	0.86	0.3	0.86	-0.03		0.38	0.29	0.04
Total Current Assets	0.76	0.73	0.57	-0.04	0.49	0.56	0.75	-0.58	0.76	0.72	0.53	0.68	0.61	0.39	0.65	0.36	0.9	0.87	0.66	0.76	0.69	0.29	0.38		0.14	0.38
Short Term Debt	0.26	0.23	0.26	0.28	0.26	0.07	0.26	-0.34	0.26	0.25	-0.02	0.24	0.26	0.3	0.3	0.23	0.06	0.09	0.29	0.16	0.24	0.11	0.29	0.14		-0.01
Intangible Assets	0.22	0.33	0.14	-0.2	-0.12	0.53	0.17	-0.08	0.17	0.09	0.48	0.15	0.15	-0.05	0.2	0.11	0.26	0.21	0.26	0.59	0.21	0.28	0.04	0.38	-0.01

Click cells to compare fundamentals

Bruker Account Relationship Matchups

Bruker fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.8B	3.0B	3.7B	3.6B	4.2B	4.5B
Total Stockholder Equity	917.1M	975.6M	1.1B	1.1B	1.4B	1.4B
Non Current Assets Total	975.2M	1.1B	1.2B	1.5B	2.1B	2.2B
Non Currrent Assets Other	16.8M	39.6M	70.8M	(99.8M)	175.7M	184.5M
Other Assets	77.3M	180M	160.9M	208.9M	240.2M	252.2M
Common Stock Shares Outstanding	156.6M	154.6M	152.9M	149.4M	147.2M	143.8M
Liabilities And Stockholders Equity	2.8B	3.0B	3.7B	3.6B	4.2B	4.5B
Non Current Liabilities Total	1.2B	1.3B	1.6B	1.6B	1.6B	1.7B
Other Stockholder Equity	(333.8M)	(450.7M)	(582.5M)	(828.7M)	(954.3M)	(906.6M)
Total Liab	1.9B	2.1B	2.6B	2.5B	2.8B	3.0B
Short Long Term Debt Total	860.3M	891.5M	1.3B	1.2B	1.4B	1.4B
Other Current Liab	388.8M	210.1M	234.4M	596.8M	316.2M	237.4M
Total Current Liabilities	645.6M	793.6M	938.5M	913.8M	1.2B	1.3B
Property Plant And Equipment Net	371.7M	462.9M	406.1M	487M	691.4M	726.0M
Net Debt	182M	209.7M	266M	573.7M	891.3M	935.9M
Retained Earnings	1.3B	1.4B	1.7B	1.9B	2.3B	2.4B
Accounts Payable	118.4M	134.6M	147.4M	178.4M	202.7M	212.8M
Cash	678.3M	681.8M	1.1B	645.5M	488.3M	311.3M
Cash And Short Term Investments	684.9M	731.8M	1.2B	645.5M	488.3M	358.2M
Net Receivables	362.2M	335.3M	416.9M	595.3M	621.8M	652.9M
Inventory	577.2M	692.3M	710.1M	803.7M	968.3M	1.0B
Other Current Assets	172M	165.6M	176.6M	72.3M	85.8M	108.0M
Property Plant And Equipment Gross	371.7M	462.9M	406.1M	487M	1.2B	1.3B
Total Current Assets	1.8B	1.9B	2.5B	2.1B	2.2B	1.1B
Accumulated Other Comprehensive Income	(25.5M)	3.7M	(8.2M)	14.8M	6M	5.7M
Short Term Debt	500K	23.5M	130.3M	35.1M	144.5M	151.7M
Intangible Assets	603.5M	229.1M	211.8M	270.9M	330.5M	196.5M
Other Liab	311M	389.4M	404.9M	318.2M	365.9M	384.2M
Long Term Debt	812.8M	842.3M	1.2B	1.2B	1.2B	1.2B
Short Term Investments	0.0	6.6M	50M	100M	12M	11.4M
Property Plant Equipment	306.1M	395.5M	406.1M	487M	560.1M	588.1M
Current Deferred Revenue	137.9M	189.2M	197.5M	225.7M	400M	420M
Treasury Stock	(543.8M)	(667M)	(820.3M)	(1.1B)	(976.5M)	(927.7M)
Good Will	293M	320.4M	339.5M	457.6M	582.6M	611.7M
Net Tangible Assets	491.5M	509.6M	312.5M	1.2B	1.4B	1.5B
Noncontrolling Interest In Consolidated Entity	10.3M	13.1M	14.1M	11.9M	13.7M	8.2M
Retained Earnings Total Equity	1.3B	1.4B	1.7B	1.9B	2.2B	2.3B
Long Term Debt Total	812.8M	842.3M	1.2B	1.2B	1.4B	1.4B

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

0.86	A	Agilent Technologies	Pair Corr
0.88	ME	23Andme Holding	Pair Corr
0.64	VALN	Valneva SE ADR	Pair Corr

Moving against Bruker Stock

0.78	DRUG	Bright Minds Biosciences	Pair Corr
0.61	VANI	Vivani Medical	Pair Corr
0.58	VCYT	Veracyte	Pair Corr
0.55	VCEL	Vericel Corp Ord	Pair Corr
0.5	VERA	Vera Therapeutics	Pair Corr

The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.

The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Bruker Stock Analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC